You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 3, 14 February 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (52)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Manifestations of Vasculitis in Patients With Solid Tumors

A Case Report and Review of the Literature

Razelle Kurzrock, MD; Philip R. Cohen, MD; Avi Markowitz, MD

Arch Intern Med. 1994;154(3):334-340.


Abstract

Vasculitis is characterized by inflammatory changes and necrosis of blood vessels. Involvement of arteries and veins of diverse sizes throughout the body is possible and results in a multiplicity of clinical manifestations. Primary and secondary forms of vasculitis exist. Secondary vasculitis has been linked to several processes, including infections, drugs, and allergic, rheumatologic, and neoplastic disease. The majority of patients with malignant neoplasm—associated vasculitis who have been described had hematologic neoplasms. We report a patient with adenocarcinoma of the colon and vasculitis and review the 36 cases of vasculitis in patients with solid tumors documented in the world literature. The most common malignant neoplasms were non—small-cell lung cancer and prostate, breast, colon, and renal cancer. Cutaneous leukocytoclastic vasculitis and nerve and muscle microvasculitis were the most frequently observed vasculitic subtypes. Importantly, in 71% of the cases, manifestations of vasculitis appeared before or concurrent with the initial recognition or the relapse of the tumor. Management strategies that met with success in at least half the patients in whom they were used included corticosteroids, cyclophosphamide, and treatment of the underlying cancer. Prognosis may be primarily related to the ability to control the malignant neoplasm, as most of the patients who died did so because of tumor progression.

(Arch Intern Med. 1994;154:334-340)



Author Affiliations

From the Departments of Clinical Investigation and Hematology (Dr Kurzrock), Gastrointestinal Oncology (Dr Markowitz), and Medical Specialties, Section of Dermatology (Dr Cohen), The University of Texas M. D. Anderson Cancer Center, Houston, and the Department of Dermatology, University of Texas Medical School, Houston (Dr Cohen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?
Hellmich et al.
Ann Rheum Dis 2004;63:1183-1185.
FULL TEXT  

Skin Lesions of Sweet Syndrome and Its Dorsal Hand Variant Contain Vasculitis: An Oxymoron or an Epiphenomenon?
Cohen
Arch Dermatol 2002;138:400-403.
FULL TEXT  

Pulmonary nodules and splinter haemorrhages
Postgrad. Med. J. 2001;77:792-792.
FULL TEXT  

Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies
Abu-Shakra et al.
Ann Rheum Dis 2001;60:433-441.
ABSTRACT | FULL TEXT  

Polyarteritis nodosa associated with cholangiocarcinoma
Hatzis et al.
Lupus 1998;7:301-306.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.